Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics
Nikolov, A.; Kovachev, I.; Petkov, I.; Dimitrov, A.
Akusherstvo i Ginekologiia 39(3): 35-40
2000
ISSN/ISBN: 0324-0959 PMID: 11187995 Document Number: 521904
Document emailed within 1 workday
Related Documents
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839Vallano, A.; Arnau, J.M.; Vallés, J.A. 1991: Prophylaxis of venous thrombosis and low-molecular-weight heparin Medicina Clinica 97(7): 272-275
Velut, J.G.; Boubli, L.; Lheureux, G.; d'Ercole, C.; Harlé, J.R.; Bagnères, D.; Frances, Y. 2001: Low-molecular-weight heparin prophylaxis during pregnancy: a retrospective study in 119 women Presse Medicale 30(13): 635
Bacher, P.; Horst, B.; Breyer, H.G.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: Postoperative monitoring of low molecular weight heparin prophylaxis in high-risk patients Seminars in Thrombosis and Hemostasis 19(Suppl 1): 73-78
Grunebaum, L.; Fricker, J.P.; Wiesel, M.L.; Vergnes, Y.; Kapps, J.; Cazenave, J.P. 1987: Preliminary results of a randomized trial comparing the efficacy of standard heparin with that of fragmine, a low molecular weight heparin, in the prevention of postoperative thrombosis in cancer surgery Journal des Maladies Vasculaires 12 Suppl B: 102-104
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Horlocker, T.T.; Heit, J.A. 1997: Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management Anesthesia and Analgesia 85(4): 874-885
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Kumar, A.; Nainiwal, S.; Sreenivas, B. 2003: Intravitreal low molecular weight heparin in PVR surgery Indian Journal of Ophthalmology 51(1): 67-70
Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Planes, A.; Vochelle, N.; Bouthier, J.; Fagola, M.; Bellaud, M. 1991: Use of enoxaparin, a low molecular weight heparin, in elective hip surgery Seminars in Thrombosis and Hemostasis 17(Suppl 3): 296-303
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Jørgensen, P.S.; Knudsen, J.B.; Broeng, L.; Josephsen, I.L.; Bjerregaard, P.; Hagen, K.K.; Jørgensen, P.K.; Tørholm, C. 1993: The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. a placebo controlled trial Ugeskrift for Laeger 155(10): 706-708
Hassn, A.; Hassan, A.M. 1999: Treatment with low molecular weight heparin needs anticoagulation monitoring Journal of the American College of Surgeons 189(1): 141-142
Evarts, C.M.; Feil, E.I. 1971: Thromboembolism after elective surgery of the hip. Detection, natural history, prophylaxis, and results with low molecular weight dextran Orthopedic Clinics of North America 2(1): 167-174
Borris, L.C.; Lassen, M.R.; Jensen, H.P.; Andersen, B.S.; Poulsen, K.A. 1994: Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations International Journal of Clinical Pharmacology and Therapeutics 32(5): 262-268
Paul, V.; Pudoor, A.; Earali, J.; John, B.; Anil Kumar, C.S.; Anthony, T. 2007: Trial of low molecular weight heparin in the treatment of viper bites Journal of the Association of Physicians of India 55: 338-342